European Companies Search Engine
15 EU fundings (total €5,986,710): 101062042 - Mrdaml - Deciphering the Mechanistic Basis of Minimal Residual Disease and Treatment Resistance in Acute Myeloid Leukemia … BdlYear 2023 Financial Transparency System
Text
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, Heidelberg, Germany
This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, Heidelberg, Germany.
The visualizations for "Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts - 15 EU fundings (total €5,986,710): 101062042 - Mrdaml - Deciphering the Mechanistic Basis of Minimal Residual Disease and Treatment Resistance in Acute Myeloid Leukemia …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.